Related Experiment Video
Updated: Aug 14, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Short-term induction and long-term suppression of HPV16 oncogene silencing by RNA interference in cervical cancer
1HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1868, USA.
Abstract:
RNA interference-mediated gene silencing has the potential to block gene expression. A synthetic double-stranded small interfering RNA (siRNA) based on a sequence motif of 21 nucleotides from human papillomavirus 16 (HPV16) E6E7 bicistronic RNA was found to be a potent siRNA that suppresses expression of both the E6 and E7 oncogenes in HPV16+ CaSki and SiHa cells. When stably expressed as a short hairpin RNA in these cells, however, siRNA silencing of E6 and E7 expression was efficient only at early cell passages, but became inefficient with increased cell passages despite the continued expression of the siRNA at the same level. The loss of the siRNA function was duplicable in stable p53 siRNA cells, but not in stable lamin A/C siRNA cells, suggesting that it is gene selective. The cells resistant to siRNA function retained normal siRNA processing, duplex unwinding and degradation of the unwound sense strand and RNA-induced silencing complex formation, suggesting that loss of the siRNA function occurred at a later step. Surprisingly, the siRNA-resistant cells were found to express notably a cytoplasmic protein of approximately 50 kDa that specifically and characteristically interacted with the unwound, antisense strand E7 siRNA. Altogether, our data indicate that a potent siRNA targeting to an essential or regulatory gene might induce a cell to develop siRNA-suppressive function.
Insights
Potent small interfering RNA (siRNA) targeting human papillomavirus 16 (HPV16) oncogenes lost function over time in cell culture. Cells developed a suppressive mechanism involving a cytoplasmic protein that interfered with siRNA activity.
Area of Science:
- Molecular Biology
- Virology
- Gene Regulation
Background:
- RNA interference (RNAi) is a powerful tool for gene silencing.
- Small interfering RNA (siRNA) can suppress gene expression by targeting specific RNA sequences.
Purpose of the Study:
- To investigate the long-term efficacy and potential resistance mechanisms of siRNA targeting human papillomavirus 16 (HPV16) oncogenes.
- To understand how siRNA gene silencing function is maintained or lost in cancer cells.
Main Methods:
- Developed and stably expressed short hairpin RNA (shRNA) targeting HPV16 E6E7 oncogenes in HPV16+ cancer cells (CaSki and SiHa).
- Assessed siRNA silencing efficiency across different cell passages.
- Analyzed siRNA processing, RNA-induced silencing complex (RISC) formation, and protein interactions in resistant cells.
Main Results:
- siRNA-mediated silencing of HPV16 E6 and E7 oncogenes was potent initially but became inefficient with increased cell passages.
- Loss of siRNA function was gene-selective and occurred after initial siRNA processing steps.
- siRNA-resistant cells uniquely expressed a ~50 kDa cytoplasmic protein that specifically interacted with the antisense strand of the E7 siRNA.
Conclusions:
- Potent siRNA targeting essential or regulatory genes can induce cellular mechanisms to suppress siRNA function.
- This suggests a potential cellular defense against highly effective gene silencing strategies.
- Further research is needed to elucidate the precise mechanism of this siRNA suppressive function.
Related Concept Videos
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
MicroRNAs
Non-LTR Retrotransposons
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Mechanisms of Retrovirus-induced Cancers
